World's Best Scientists 2026 revealed!
Jan Balzarini

Jan Balzarini

Award Badge
Biology and Biochemistry
Belgium
2026
Award Badge
Chemistry
Belgium
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
133
Citations
76433
World Ranking
370
National Ranking
6

Chemistry

D-Index
129
Citations
72342
World Ranking
342
National Ranking
5

Jan Balzarini publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Jan Balzarini sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 1,801 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Jan Balzarini D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Jan Balzarini sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 129 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in Belgium Leader Award
  • 2026 - Research.com Chemistry in Belgium Leader Award
  • 2025 - Research.com Biology and Biochemistry in Belgium Leader Award
  • 2025 - Research.com Chemistry in Belgium Leader Award
  • 2023 - Research.com Microbiology in Belgium Leader Award
  • 2022 - Research.com Chemistry in Belgium Leader Award
  • 2022 - Research.com Microbiology in Belgium Leader Award
  • 2003 - Member of the European Academy of Sciences

Overview

Jan Balzarini is affiliated with KU Leuven in Belgium and has made contributions primarily in the field of Chemistry, with a focus on Organic Chemistry. Their work also spans subfields such as Food Science and Pharmacology. The scientist's research emphasizes synthesis and biological activity, including synthesis and biological evaluation, the characterization of heterocyclic compounds, essential oils with antimicrobial activity, and studies related to cholinesterase and neurodegenerative diseases.

Frequent coauthors in their research include Sandra Liekens, Stefano Manfredini, Romeo Romagnoli, Filippo Prencipe, and Paola Oliva. This indicates a collaborative research environment across multiple projects, with specific recurring partnerships.

Jan Balzarini has contributed papers published in several notable scientific journals. These include:

  • Benzothiazole Derivatives as Multifunctional Antioxidant Agents for Skin Damage: Structure-Activity Relationship of a Scaffold Bearing a Five-Membered Ring System (2022, Antioxidants)
  • Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization (2020, Bioorganic Chemistry)
  • Synthesis and Biological Evaluation of New Antitubulin Agents Containing 2-(3',4',5'-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold (2020, Molecules)

The scientist's publications have appeared primarily in the journals Antioxidants, Bioorganic Chemistry, and Molecules.

The main research topics covered by Jan Balzarini include:

  • Synthesis and biological activity
  • Synthesis and Biological Evaluation
  • Synthesis and Characterization of Heterocyclic Compounds
  • Essential Oils and Antimicrobial Activity
  • Cholinesterase and Neurodegenerative Diseases

Jan Balzarini was recognized as a Member of the European Academy of Sciences in 2003. This membership indicates professional acknowledgement within the scientific community.

Best Publications

  • Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

    Rudi Pauwels;Jan Balzarini;Masanori Baba;Robert Snoeck

  • A novel selective broad-spectrum anti-DNA virus agent.

    Erik De Clercq;Antonin Holý;Ivan Rosenberg;Takashi Sakuma

  • 1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activity.

    Rosa Alvarez;Sonsoles Velázquez;Ana San-Félix;Stefano Aquaro

  • Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines.

    Erik De Clercq;Takashi Sakuma;Masanori Baba;Rudi Pauwels

  • Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.

    M Baba;R Pauwels;J Balzarini;J Arnout

  • Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs

    J Wijnholds;C A Mol;L van Deemter;M de Haas

  • A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.

    Tadashi Miyasaka;Hiromichi Tanaka;Masanori Baba;Hiroyuki Hayakawa

  • Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma

    K. Spaepen;S. Stroobants;P. Dupont;P. Vandenberghe

  • Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18f]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma : Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

    Karoline Spaepen;Sigrid Stroobants;Patrick Dupont;Steven Van Steenweghen

  • Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.

    J Balzarini;P Herdewijn;E De Clercq

  • Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine.

    J Balzarini;A Holy;J Jindrich;L Naesens

  • 3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents.

    P Herdewijn;J Balzarini;E De Clercq;R Pauwels

  • Synthesis and antiviral activity of new pyrazole and thiazole derivatives

    Osama I. El-Sabbagh;Mohamed M. Baraka;Samy M. Ibrahim;Christophe Pannecouque

  • Characterization of the Transport of Nucleoside Analog Drugs by the Human Multidrug Resistance Proteins MRP4 and MRP5

    Glen Reid;Peter Wielinga;Noam Zelcer;Marcel de Haas

  • Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.

    M. Baba;H. Tanaka;E. De Clercq;R. Pauwels

  • Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100.

    E De Clercq;N Yamamoto;R Pauwels;J Balzarini

  • Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.

    Jan Balzarini

  • The ProTide Prodrug Technology: From the Concept to the Clinic

    Youcef Mehellou;Hardeep S. Rattan;Jan Balzarini

  • Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents.

    R Pauwels;J Balzarini;D Schols;M Baba

  • Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite

    Christopher McGuigan;Dominique Cahard;Hendrika M. Sheeka;Erik De Clercq

  • The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.

    J Balzarini;G J Kang;M Dalal;P Herdewijn

Frequent Co-Authors

Erik De Clercq
Erik De Clercq Rega Institute for Medical Research
Robert Snoeck
Robert Snoeck KU Leuven
Christophe Pannecouque
Christophe Pannecouque Rega Institute for Medical Research
Lieve Naesens
Lieve Naesens Rega Institute for Medical Research
Johan Neyts
Johan Neyts Rega Institute for Medical Research
Antonín Holý
Antonín Holý Czech Academy of Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a Chemistry degree in the USA opens doors to various related online degrees and career options. For those looking to transition into fields like law enforcement or legal studies, exploring a criminal justice degree price can help you assess affordability and plan your education budget effectively.

Many students opt for flexibility by enrolling in a 2 year criminal justice degree online, which provides foundational knowledge and opens pathways to various entry-level roles in law enforcement and public safety.

For graduates interested in legal support roles, understanding what types of paralegals make the most money is crucial for aligning career goals and choosing the right specialization within paralegal studies.

Additionally, Chemistry graduates can transition into the pharmaceutical industry. Careers such as pharmaceutical sales require both scientific expertise and communication skills. To explore earnings and growth opportunities, review details on pharma sales rep salary and career paths.

Best Scientists Citing Jan Balzarini

Trending Scientists

Recently Published Articles